Skip to main content

Neuroendoscopy Market: What are the major tailwinds and headwinds for the market?

According to a new market research report "Neuroendoscopy Market by Product (Rigid (Videoscope, Fiberscope), Flexible endoscope), Usability (Reuse and Disposable), Application (Transnasal, Intraventricular, and Transcranial), Region (North AmericaEuropeAsia) - Global Forecast to 2022", published by MarketsandMarkets™, the global market is expected to reach USD 218.9 Million by 2022 from USD 170.5 Million in 2017, at a CAGR of 5.1%.

Browse 75 market data Tables and 22 Figures spread through 101 Pages and in-depth TOC on "Neuroendoscopy Market".

The growth of the Neuroendoscopy Market is attributed to favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery.

Rigid neuroendoscopes dominated the market in 2017.

Based on product, the Neuroendoscopy Market is segmented into rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopy segment is further classified into rigid videoscopes and rigid fiberscopes. In 2017, the rigid neuroendoscopes segment accounted for the largest share of the Neuroendoscopy Devices market. This large share can be attributed to their reduced size, affordable pricing, and shock resistance.

Based on application, the transcranial neuroendoscopy segment is projected to grow at the highest CAGR during the forecast period.

Based on application, the Neuroendoscopy Market is segmented into intraventricular neuroendoscopy, transcranial neuroendoscopy, and transnasal neuroendoscopy. The transcranial segment is expected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to their wide application in the diagnosis and treatment of larger tumors with significant suprasellar extension and growing incidence of brain tumors in the population.

Ask for PDF Brochure @
https://www.marketsandmarkets.com/pdfdownload.asp?id=68126508

North America dominated the Neuroendoscopy Market in 2017

In 2017, North America dominated the market followed by Europe. The large share of this geographical segment is attributed to favorable reimbursement scenario in the US, rising incidence of cancer, increasing investments by hospitals to purchase new neuroendoscopic equipment, increasing research activities, and implementation of a new funding model for Canadian hospitals.

The Neuroendoscopy Market includes various small and large players. Key players in this market are KARL STORZ(Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US).

Know more about the Neuroendoscopy Market:
https://www.marketsandmarkets.com/Market-Reports/neuroendoscopy-market-68126508.html

Comments

Popular posts from this blog

Best Accounting Software to Kick-start the Business for Smaller Firms – Xero

  Xero Accounting Software is an online software mainly designed for the accounting needs of small business firms. The software can be operated from a PC, phone, tablet, or Mac to view the cash flows of the company in real-time. The software is for small business houses and hence it is simple to use yet smart so that the users can devote most of the time in other important areas of their business. USP of This Software: Xero accounting software offers accounting services to small business firms in a smarter way. Some of the USPs of the software the more than 800apps integrated into the software, secure encryption, support system better performance report generation, and others apart from the basic accounting services offered. Best Accounting Software for Medium-Sized Businesses@ https://blog.360quadrants.com/2020/best-accounting-software-for-medium-sized-businesses/ Xero Pricing Xero accounting software offers 30 days of free trial after which you can choose from any of the pri...

Risk-based Monitoring Software Market | Key Factor in Clinical Trial | Market Growth Worth $511 million

  Growth in the risk based monitoring software market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials. However, the high implementation cost of RBM solutions is expected to restrain the growth of this market during the forecast period. RBM Software Market Dynamics: Impact Analysis 1. Increased outsourcing of clinical trial processes to CROs 2. Cost and time efficiency of RBM solutions 3. Increasing government funding and grants to support clinical trials 4. Increased pharmaceutical R&D spending 5. Initiatives to boost digital health to propel market growth The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102112429 Software Component: The sof...

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, foll...